Black Diamond Therapeutics Inc. (BDTX)
NASDAQ: BDTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BDTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $104.86M
- EPS (TTM)
- -$0.75
- Dividend yield
- None
- 52-week range
- 1.60 – 4.94
- Day range
- 1.78 – 1.87
- Volume / Avg
- 562.61K / 642.65K
- Beta
- —
- Shares outstanding
- 57.30M
- Next earnings
- Nov 5, 2026
52-week range
BDTX stock today
Shares of Black Diamond Therapeutics (BDTX) finished higher on Oct 7 at $1.83, a gain of 1.67% or $0.03 per share, versus the S&P 500's 0.22% decline. At this level, BDTX sits near the bottom of its 52-week range of $1.60 to $4.94: 63.0% below the high, set on Nov 12, 2025 and 14.4% above the low. BDTX is down 24.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 53.2%.
Black Diamond Therapeutics has posted a net loss over the last twelve months (EPS of -$0.75), so its P/E ratio is not meaningful. Black Diamond Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Black Diamond Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2020
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.03
Black Diamond Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ATRAAtara Biotherapeutics Inc. | 9.37 | -3.90% | $94.05M | vs BDTX |
| LENZLENZ Therapeutics Inc. | 3.62 | -4.49% | $113.74M | vs BDTX |
| ENGNenGene Therapeutics Inc. | 1.75 | -3.06% | $116.94M | vs BDTX |
| CGTXCognition Therapeutics Inc. | 0.9366 | -0.36% | $89.06M | vs BDTX |
| NMRANeumora Therapeutics Inc. | 0.4683 | -0.57% | $87.99M | vs BDTX |
| TNYATenaya Therapeutics Inc. | 0.5334 | -2.40% | $119.60M | vs BDTX |
| CRDFCardiff Oncology Inc. | 1.09 | +1.87% | $84.80M | vs BDTX |
| PTHSPelthos Therapeutics Inc. | 20.99 | -2.28% | $80.36M | vs BDTX |
Indexes, lists and sector
Black Diamond Therapeutics stock FAQ
What is Black Diamond Therapeutics's stock price today?
BDTX last traded at $1.83 as of Oct 7, 4:00 PM EDT, up 1.67% on the day. Prices are delayed at least 15 minutes.
When is Black Diamond Therapeutics's next earnings date?
Black Diamond Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.03.
What is the BDTX 52-week high?
The 52-week high for BDTX is $4.94 and the 52-week low is $1.60. The stock is currently 63.0% below its high.